Sofia Garcia was named director of the Cancer Survivorship Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
The Mark Foundation for Cancer Research awarded six new Emerging Leader Awards, totaling $4.5 million, to early-career investigators for projects aimed at addressing unmet needs in cancer research.
Gifts totaling $3 million will create an endowed chair in cancer informatics at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Joel Helmke, chief operating officer of Fox Chase Cancer Center, has been named vice chair of the board of directors of the Alliance of Dedicated Cancer Centers.
Andrea Wolf, director of the New York Mesothelioma Program at the Mount Sinai Health System, received the 2022 Irving J. Selikoff Lifetime Achievement Award from the Asbestos Disease Awareness Organization.
Jennifer Wargo, professor of surgical oncology and genomic medicine at MD Anderson Cancer Center, received a 2023 Edith and Peter O’Donnell Award in Medicine from the Texas Academy of Medicine, Engineering, Science and Technology for her contributions to the understanding of how the gut microbiome influences responses to immunotherapy and other cancer treatments.
The Stem Cell and Bone Marrow Transplant Program at Cedars-Sinai Cancer was recognized with official accreditation for CAR T-cell therapy from the Foundation for the Accreditation of Cellular Therapy, an international accrediting body. The program was also ranked among the top adult bone marrow transplant programs in the U.S. for a third year.
Roswell Park has opened the Marie E. Bogner Center for Nursing Excellence. The 5,126 square-foot space houses smart classrooms, flexible skills learning areas, and a lactation room.
Yale Cancer Center’s Annual Conclave, held on Jan. 5, recognized the scientific and clinical accomplishments of Smilow Cancer Hospital and Yale Cancer Center over the past year.
Rachel Abbott was named chief scientific officer of Pan Cancer T, a biotech spin-off from Erasmus MC focused on the discovery and development of next-generation TCR-T therapies against solid tumors.
